Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Factors Influencing Luciferase-Based Bioluminescent Imaging in Preclinical Models of Brain Tumor

Drug Metabolism and Disposition(2021)10.1124/dmd.121.000597Source: DataRank Database

Factors Influencing Luciferase-Based Bioluminescent Imaging in Preclinical Models of Brain Tumor is a research paper published in Drug Metabolism and Disposition (2021). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.59)OA: bronzeTopics (47)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Shiv K. Gupta ORCID,Wenjuan Zhang ORCID,Surabhi Talele ORCID,Afroz S. Mohammad,Janice K. Laramy

Live enrichment

PubMed:34887255 PMC:PMC8969130 OpenAlex:https://openalex.org/W4200342761

NCI NIH HHS

Grant: R01 CA138437

NINDS NIH HHS

Grant: R01 NS077921

NCI NIH HHS

Grant: U01 CA227954

NCI NIH HHS

Grant: U54 CA210181

National Institutes of Health

Grant: 5U01CA227954-02

Pre-Clinical Novel Radiosensitizer Evaluation Program for Brain Tumors

National Institutes of Health

Grant: 5U54CA210181-05

Center for Immunotherapeutic Transport Oncophysics

National Institutes of Health

Grant: 5R01NS077921-03

Influence of Anti-Angiogenic Therapy on Drug Delivery to Brain Tumors

National Institutes of Health

Grant: 5R01CA138437-05

Improving Delivery of Molecularly-Targeted Therapy to Invasive Glioma Cells

FWCI

0.59

Citation Percentile

0.6%

Citation Trend

2022

2023

2024

2025

2026

bronzeLicense: Elsevier TDM

journalhttps://dmd.aspetjournals.org/content/dmd/50/3/277.full.pdf

publisherhttps://dmd.aspetjournals.org/content/dmd/50/3/277.full.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0090955624007451?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0090955624007451?httpAccept=text/plain

publisherhttps://syndication.highwire.org/content/doi/10.1124/dmd.121.000597

Fields of Study

bioluminescence and chemiluminescence researchCell Image Analysis Techniques3D Printing in Biomedical Research0301 basic medicine03 medical and health sciencesATP Binding Cassette Transporter, Subfamily G, Member 2Brain NeoplasmsHumansLuciferasesLuciferases, FireflyLuminescent MeasurementsNeoplasm ProteinsTissue Distribution

MeSH Terms

ATP Binding Cassette Transporter, Subfamily G, Member 2Brain NeoplasmsHumansLuciferasesLuminescent MeasurementsNeoplasm ProteinsTissue DistributionLuciferases, Firefly

Keywords

LuciferaseLuciferinBioluminescenceBioluminescence imagingEffluxPharmacologyTransporterBlood–brain barrierDistribution (mathematics)Cell biologyChemistryBiochemistryBiologyBiophysicsNeuroscienceGeneCentral nervous systemTransfectionBrain NeoplasmsLuciferases, FireflyLuminescent MeasurementsATP Binding Cassette Transporter, Subfamily G, Member 2HumansTissue DistributionLuciferasesNeoplasm Proteins

Sustainable Development Goals

SDG 0: Good health and well-being